Capital Research Global Investors’s Endo International plc ENDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-863,000
Closed -$7.39M 455
2017
Q3
$7.39M Sell
863,000
-9,659,588
-92% -$93.1M ﹤0.01% 411
2017
Q2
$118M Sell
10,522,588
-4,460,840
-30% -$52.4M 0.04% 267
2017
Q1
$167M Sell
14,983,428
-688,300
-4% -$8.55M 0.05% 246
2016
Q4
$258M Buy
+15,671,728
New +$276M 0.08% 207
2014
Q1
Sell
-14,073,200
Closed -$949M 439
2013
Q4
$949M Buy
14,073,200
+4,767,400
+51% +$272M 0.35% 84
2013
Q3
$423M Sell
9,305,800
-185,600
-2% -$7.47M 0.17% 142
2013
Q2
$349M Buy
+9,491,400
New +$341M 0.15% 146

Other funds holding ENDP

Capital Research Global Investors's ENDP Position: Q4 2017 in Review

Capital Research Global Investors sold out of Endo International plc (ENDP) in Q4 2017, closing a stake of 863,000 shares — an estimated $7.39M sold.

Capital Research Global Investors first reported a position in ENDP in Q2 2013 and held it in 7 quarters. The position peaked at $949M in Q4 2013. 237 funds tracked by Wall St. Rank hold ENDP as of Q4 2017.

  • Capital Research Global Investors reported no remaining Endo International plc position as of Q4 2017 after selling out during the quarter.
  • Capital Research Global Investors sold 863,000 Endo International plc shares in Q4 2017, an estimated $7.39M.
  • Capital Research Global Investors first reported a position in Endo International plc in Q2 2013 and held it in 7 quarters.
  • Capital Research Global Investors's Endo International plc position peaked at $949M in Q4 2013.
  • 237 funds tracked by Wall St. Rank held Endo International plc as of Q4 2017.

Based on Capital Research Global Investors's 13F filing for Q4 2017, filed 14 Feb 2018.